UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer

Gynecologic oncology, 2020-02, Vol.156 (2), p.393-399

2020

Volltextzugriff (PDF)

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Journal of clinical oncology, 2023-01, Vol.41 (2), p.276-284

2023

Volltextzugriff (PDF)

Molecular profiles of endometrial cancer tumors among Black patients

Gynecologic oncology, 2022-07, Vol.166 (1), p.108-116

2022

Volltextzugriff (PDF)

Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer Imaging

IEEE photonics journal, 2021-02, Vol.13 (1), p.1-10

2021

Volltextzugriff (PDF)

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy

Gynecologic oncology, 2022-11, Vol.167 (2), p.289-294

2022

Volltextzugriff (PDF)

Miniaturized phased-array ultrasound and photoacoustic endoscopic imaging system

Photoacoustics (Munich), 2019-09, Vol.15, p.100139-100139, Article 100139

2019

Volltextzugriff (PDF)

Effective expression of small interfering RNA in human cells

Nature biotechnology, 2002-05, Vol.20 (5), p.505-508

2002

Volltextzugriff (PDF)

Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?

Journal of minimally invasive gynecology, 2021-09, Vol.28 (9), p.1625-1632

2021

Volltextzugriff (PDF)

Management of squamous cell vulvar cancer: A review

The journal of obstetrics and gynaecology research, 2014-05, Vol.40 (5), p.1217-1225

2014

Volltextzugriff (PDF)

ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity

Cancer medicine (Malden, MA), 2021-05, Vol.10 (10), p.3373-3387

2021

Volltextzugriff (PDF)

Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer

Frontiers in oncology, 2022-03, Vol.12, p.842441-842441

2022

Volltextzugriff (PDF)

Tumor-associated macrophages derived from cancer stem cells

Acta histochemica, 2020-12, Vol.122 (8), p.151628-151628, Article 151628

2020

Volltextzugriff (PDF)

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

Cancer research communications, 2024-10, Vol.4 (10), p.2598-2609

2024

Volltextzugriff (PDF)

Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease

American journal of obstetrics and gynecology, 2012-07, Vol.207 (1), p.e9-e11

2012

Volltextzugriff (PDF)

Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5503-5503

2021

Volltextzugriff (PDF)

708 A phase 1/2 study of rinatabart sesutecan (PRO1184), a novel folate receptor alpha-directed antibody-drug conjugate, in patients with locally advanced and/or metastatic solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A803-A803

2023

Volltextzugriff (PDF)

Lysine Residues Lys-19 and Lys-49 of β-Catenin Regulate Its Levels and Function in T Cell Factor Transcriptional Activation and Neoplastic Transformation

The Journal of biological chemistry, 2006-09, Vol.281 (36), p.26181-26187

2006

Volltextzugriff (PDF)

Chemotherapy of vulvar cancer: a review

Wiener Klinische Wochenschrift, 2013-03, Vol.125 (5-6), p.119-128

2013

Volltextzugriff (PDF)

531 A Phase 1b multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors: results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A562-A562

2021

Volltextzugriff (PDF)

Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study

International journal of gynecological pathology, 2013-03, Vol.32 (2), p.181-187

2013

Volltextzugriff (PDF)

CUDC-907, a dual HDAC and PI3K inhibitor, to inhibit cancer progression both in high and low grade ovarian carcinoma cell lines

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e17556-e17556

2018

Volltextzugriff (PDF)

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

Case reports in obstetrics and gynecology, 2016-01, Vol.2016 (2016), p.1-4

2016

Volltextzugriff (PDF)

347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A211-A212

2020

Volltextzugriff (PDF)

Prevalence of targetable and potentially targetable alterations in metastatic/recurrent cervical cancer specimens in a large genomic dataset

Gynecologic oncology, 2024-11, Vol.190, p.S232-S233

2024

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(106)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Molecular profiles of endometrial cancer tumors among Black patients

Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer Imaging

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy

Miniaturized phased-array ultrasound and photoacoustic endoscopic imaging system

Effective expression of small interfering RNA in human cells

Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?

Management of squamous cell vulvar cancer: A review

ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity

Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer

Tumor-associated macrophages derived from cancer stem cells

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease

Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer

708 A phase 1/2 study of rinatabart sesutecan (PRO1184), a novel folate receptor alpha-directed antibody-drug conjugate, in patients with locally advanced and/or metastatic solid tumors

Lysine Residues Lys-19 and Lys-49 of β-Catenin Regulate Its Levels and Function in T Cell Factor Transcriptional Activation and Neoplastic Transformation

Chemotherapy of vulvar cancer: a review

531 A Phase 1b multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors: results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts

Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study

CUDC-907, a dual HDAC and PI3K inhibitor, to inhibit cancer progression both in high and low grade ovarian carcinoma cell lines

Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge

347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial

Prevalence of targetable and potentially targetable alterations in metastatic/recurrent cervical cancer specimens in a large genomic dataset

Suchergebnisse filtern